Many people liken the field of heart failure to oncology. Both fields treat a heterogenous group of diseases simplistically referred to as heart failure or cancer. Both share the extremes of victory and loss. Both offer an opportunity for intense patient-physician bonds that are sometimes counterbalanced by difficult end-of-life conversations. Both sometimes force us to engage in uncomfortable discussions about the ineffectiveness of our modern medicine in treating certain diseases. And both offer a unique insight to the questions that dying individuals have to confront, sometimes alone.
Khedraki R. Tolstoy in Medicine. JAMA Cardiol. Published online November 27, 2019. doi:https://doi.org/10.1001/jamacardio.2019.4545
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: